Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of August 2026

Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of August 2026

  1. Absci Corp

    World Rank (Aug-2026)
    7,267
    Market Cap (Aug-2026)
    1.575 Billion USD
    World Rank (Jan-05-2024)
    14,874
    Market Cap (Jan-05-2024)
    0.346 Billion USD
    World Rank (Jul-30-2023)
    18,130
    Market Cap (Jul-30-2023)
    0.197 Billion USD
    World Rank (Dec-25-2022)
    18,001
    Market Cap (Dec-25-2022)
    0.200 Billion USD
    World Rank (Jan-07-2022)
    11,637
    Market Cap (Jan-07-2022)
    0.67 Billion USD
    Annual Revenue in USD
    3 Million USD
    Annual Operating Income in USD
    -120 Million USD
    Annual Net Income in USD
    -115 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Website
    ABSCI CORP

  2. Xeris Pharmaceuticals

    World Rank (Aug-2026)
    7,279
    Market Cap (Aug-2026)
    1.568 Billion USD
    World Rank (Jan-05-2024)
    14,821
    Market Cap (Jan-05-2024)
    0.349 Billion USD
    World Rank (Jul-30-2023)
    15,032
    Market Cap (Jul-30-2023)
    0.347 Billion USD
    World Rank (Dec-25-2022)
    18,889
    Market Cap (Dec-25-2022)
    0.171 Billion USD
    World Rank (Jan-07-2022)
    16,375
    Market Cap (Jan-07-2022)
    0.32 Billion USD
    Annual Revenue in USD
    292 Million USD
    Annual Operating Income in USD
    25 Million USD
    Annual Net Income in USD
    1 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Website
    XERIS PHARMACEUTICALS

  3. Innoviva

    World Rank (Aug-2026)
    7,368
    Market Cap (Aug-2026)
    1.531 Billion USD
    World Rank (Jan-05-2024)
    8,240
    Market Cap (Jan-05-2024)
    1.075 Billion USD
    World Rank (Jul-30-2023)
    9,507
    Market Cap (Jul-30-2023)
    0.861 Billion USD
    World Rank (Dec-25-2022)
    8,769
    Market Cap (Dec-25-2022)
    0.924 Billion USD
    World Rank (Jan-07-2022)
    8,422
    Market Cap (Jan-07-2022)
    1.22 Billion USD
    Annual Revenue in USD
    411 Million USD
    Annual Operating Income in USD
    164 Million USD
    Annual Net Income in USD
    271 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Innoviva is a Pharmaceutical company with a portfolio of royalties that include respiratory assets partnered with Glaxo Group Limited. The headquarters is in USA.
    Company Website
    INNOVIVA INC

  4. Tyra Biosciences Inc.

    World Rank (Aug-2026)
    7,426
    Market Cap (Aug-2026)
    1.509 Billion USD
    World Rank (Jan-05-2024)
    12,081
    Market Cap (Jan-05-2024)
    0.544 Billion USD
    World Rank (Jul-30-2023)
    11,471
    Market Cap (Jul-30-2023)
    0.611 Billion USD
    World Rank (Dec-25-2022)
    15,805
    Market Cap (Dec-25-2022)
    0.296 Billion USD
    World Rank (Jan-07-2022)
    13,416
    Market Cap (Jan-07-2022)
    0.50 Billion USD
    Annual Operating Income in USD
    -133 Million USD
    Annual Net Income in USD
    -120 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Website
    Tyra Biosciences, Inc.

  5. Harrow Health

    World Rank (Aug-2026)
    7,449
    Market Cap (Aug-2026)
    1.501 Billion USD
    World Rank (Jan-05-2024)
    13,869
    Market Cap (Jan-05-2024)
    0.407 Billion USD
    World Rank (Jul-30-2023)
    10,445
    Market Cap (Jul-30-2023)
    0.730 Billion USD
    World Rank (Dec-25-2022)
    13,521
    Market Cap (Dec-25-2022)
    0.423 Billion USD
    World Rank (Jan-07-2022)
    18,436
    Market Cap (Jan-07-2022)
    0.22 Billion USD
    Annual Revenue in USD
    272 Million USD
    Annual Operating Income in USD
    31 Million USD
    Annual Net Income in USD
    -5 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Website
    HARROW HEALTH
    Wikipedia
    Wikipedia

  6. Maravai LifeSciences Holdings Inc.

    World Rank (Aug-2026)
    7,518
    Market Cap (Aug-2026)
    1.480 Billion USD
    World Rank (Jan-05-2024)
    6,533
    Market Cap (Jan-05-2024)
    1.596 Billion USD
    World Rank (Jul-30-2023)
    4,497
    Market Cap (Jul-30-2023)
    2.874 Billion USD
    World Rank (Dec-25-2022)
    5,741
    Market Cap (Dec-25-2022)
    1.838 Billion USD
    World Rank (Jan-07-2022)
    3,616
    Market Cap (Jan-07-2022)
    4.40 Billion USD
    Annual Revenue in USD
    186 Million USD
    Annual Operating Income in USD
    -215 Million USD
    Annual Net Income in USD
    -131 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Maravai LifeSciences Holdings is a biotechnology sector company related to providing products and services into the fields of nucleic acid production, biologics safety testing and protein detection to many of the worlds leading biopharma, vaccine, diagnostics, and cell and gene therapy companies. It has 390 employees as on 2019. The headquarters is in USA.

    Company Website
    MARAVAI LIFESCIENCES HOLDINGS, INC.

  7. Oric Pharmaceuticals Inc.

    World Rank (Aug-2026)
    7,628
    Market Cap (Aug-2026)
    1.438 Billion USD
    World Rank (Jan-05-2024)
    12,752
    Market Cap (Jan-05-2024)
    0.489 Billion USD
    World Rank (Jul-30-2023)
    14,604
    Market Cap (Jul-30-2023)
    0.372 Billion USD
    World Rank (Dec-25-2022)
    17,297
    Market Cap (Dec-25-2022)
    0.229 Billion USD
    World Rank (Jan-07-2022)
    12,703
    Market Cap (Jan-07-2022)
    0.56 Billion USD
    Annual Operating Income in USD
    -143 Million USD
    Annual Net Income in USD
    -129 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    ORIC Pharmaceuticals is a Clinical Stage Biopharmaceutical company focused on discovering and developing innovative therapies that benefit patients with cancer. The company annual revenue is 1.07 billion USD and 60 employees as on 2019. The headquarters is in USA.
    Company Website
    ORIC PHARMACEUTICALS, INC.

  8. MoonLake Immunotherapeutics

    World Rank (Aug-2026)
    7,733
    Market Cap (Aug-2026)
    1.402 Billion USD
    World Rank (Jan-05-2024)
    3,968
    Market Cap (Jan-05-2024)
    3.404 Billion USD
    World Rank (Jul-30-2023)
    4,196
    Market Cap (Jul-30-2023)
    3.164 Billion USD
    World Rank (Dec-25-2022)
    14,035
    Market Cap (Dec-25-2022)
    0.390 Billion USD
    Headquarters Country
    Switzerland
    Company Profile
    MOONLAKE IMMUNOTHERAPEUTICS is a clinical stage biopharmaceutical company with the novel investigational Nanobody for the treatment of inflammation to revolutionize outcomes for patients. The headquarters is in Switzerland.
    Company Website
    MOONLAKE IMMUNOTHERAPEUTICS

  9. Phibro Animal Health Corporation

    World Rank (Aug-2026)
    7,755
    Market Cap (Aug-2026)
    1.394 Billion USD
    World Rank (Jan-05-2024)
    12,974
    Market Cap (Jan-05-2024)
    0.471 Billion USD
    World Rank (Jul-30-2023)
    11,793
    Market Cap (Jul-30-2023)
    0.582 Billion USD
    World Rank (Dec-25-2022)
    11,658
    Market Cap (Dec-25-2022)
    0.563 Billion USD
    World Rank (Jan-07-2022)
    10,512
    Market Cap (Jan-07-2022)
    0.82 Billion USD
    Annual Revenue in USD
    1,518 Million USD
    Annual Operating Income in USD
    194 Million USD
    Annual Net Income in USD
    100 Million USD
    Annual Results for Period Ending
    For year ending June-2026
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Phibro Animal Health is a contributing to a healthy and affordable food supply company by helping farmers responsibly care for their animals. The company products are Beef Cattle, Swine, Poultry, Dairy Cattle, Aqua, Mineral Nutrition, Ethanol and Performance Products. The company annual revenue is 799 million USD and 1,600 employees as on 2020. The headquarters is in USA.
    Company Website
    PHIBRO ANIMAL HEALTH CORPORATION

  10. Replimune Group

    World Rank (Aug-2026)
    7,786
    Market Cap (Aug-2026)
    1.384 Billion USD
    World Rank (Jan-05-2024)
    12,365
    Market Cap (Jan-05-2024)
    0.520 Billion USD
    World Rank (Jul-30-2023)
    7,950
    Market Cap (Jul-30-2023)
    1.172 Billion USD
    World Rank (Dec-25-2022)
    7,081
    Market Cap (Dec-25-2022)
    1.332 Billion USD
    World Rank (Jan-07-2022)
    8,400
    Market Cap (Jan-07-2022)
    1.22 Billion USD
    Annual Operating Income in USD
    -320 Million USD
    Annual Net Income in USD
    -314 Million USD
    Annual Results for Period Ending
    For year ending March-2026
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile

    Replimune Group is an emerging class of Cancer Therapeutics company that exploits the ability of viruses to selectively replicate in and kill tumors while at the same time inducing a potent, patient specific, anti tumor immune response. The headquarters is in USA.

    Facts About Company

    Replimune Group Annual Net loss for year ending Mar-2023 was -174 million USD.

    Replimune Group Annual Net loss for year ending Mar-2022 was -118 million USD.

    As on 2023, Replimune Group has 284 employees.

    Company Website
    REPLIMUNE GROUP

Share